Top compounds associated with response to JMJD1C


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.0011 1
mRNA XMD8-92 GDSC1000 pan-cancer AAC -0.00093 1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.00052 1
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.00043 1
mRNA Axitinib FIMM pan-cancer AAC 0.002 1
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.00026 1
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.00021 1
mRNA IU1 CTRPv2 pan-cancer AAC 0.00024 1
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.0012 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.00019 1
Download CSV